Pfizer Recalls Inderal Blood Pressure Medicine in Canada Over Carcinogen Concerns

18 Aug, 2024

Pfizer has recalled its long-acting blood pressure medication Inderal in Canada due to elevated levels of nitrosamines, potential carcinogens. The recall impacts 15 lots of the medication's extended-release capsules. Health Canada advises patients to consult doctors for alternatives while continuing current treatments. The move is part of ongoing efforts to address nitrosamine impurities in drugs.

READ MORE

Understanding Hepatitis C and Drug Interactions: Essential Information

19 Jul, 2024

Learn about Hepatitis C, its impact on liver health, and how different medications can interact with its treatment. This article provides valuable insights and tips to help you navigate medication safety while managing Hepatitis C, ensuring a balanced and careful approach to your health.

READ MORE

Methotrexate and Neuropathy: Effective Strategies for Managing Nerve Pain

19 Jun, 2024

Explore the link between methotrexate and neuropathy, understand its impact, and discover practical ways to manage nerve pain. This article offers insights into diagnosis, treatment options, lifestyle changes, and tips for pain relief.

READ MORE